Related Experiment Video
Updated: Jun 12, 2026

Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings
Published on: December 4, 2021
Cost-effectiveness of a pressure ulcer quality collaborative
Peter Makai1, Marc Koopmanschap, Roland Bal
1Department of Health Policy and Management, Erasmus University Rotterdam, the Netherlands. makai@bmg.eur.nl.
A quality improvement collaborative reduced pressure ulcer incidence and prevalence in Dutch long-term care. However, its long-term cost-effectiveness depends on sustaining these improvements.
Area of Science:
- Healthcare Quality Improvement
- Geriatric Care
- Public Health
Background:
- A Dutch quality improvement collaborative (QIC) implemented evidence-based pressure ulcer (PU) prevention methods across nursing homes, assisted living, and home care.
- The collaborative involved a central expert team and 25 organizational project teams to reduce PU incidence and prevalence.
- The study aimed to evaluate the cost-effectiveness of this QIC from a healthcare perspective.
Purpose of the Study:
- To determine the cost-effectiveness of a quality improvement collaborative (QIC) focused on pressure ulcer (PU) prevention in long-term care.
- To assess the impact of the QIC on PU incidence, prevalence, and patient quality of life.
- To analyze the healthcare costs associated with the QIC interventions.
Main Methods:
- A non-controlled pre-post design was used to track changes in PU incidence and prevalence in 88 patients over one year.
- Data on staff activities, materials, and PU states were collected, with Quality of Life (QoL) weights assigned.
- A Markov model, incorporating effectiveness and cost data, was developed with a probabilistic sensitivity analysis and three sustainability scenarios.
Main Results:
- Pressure ulcer incidence decreased from 15% to 4.5%, and prevalence dropped from 38.6% to 22.7% among the 88 patients.
- Average patient Quality of Life (QoL) increased by 0.02 Quality Adjusted Life Years (QALYs) over two years.
- Healthcare costs rose by approximately €2000 per patient, with an Incremental Cost-effectiveness Ratio (ICER) ranging from €78,500 to €131,000.
Conclusions:
- The QIC led to significant reductions in PU incidence and prevalence.
- In the short term, the QIC was more costly and effective than standard care, but long-term cost-effectiveness remains uncertain.
- Sustained improvements in PU incidence and prevalence are crucial for the QIC to be considered cost-effective in the long run.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Chronic Pancreatitis II: Collaborative Care
Assessment:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Acute Kidney Injury V: Interprofessional Care
Standards of Care II
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
